The mutation spectrum revealed by paired genome sequences from a lung cancer patient

Nature

Volumn 465, Issue 7297, 2010, Pages 473-477

  Lee, William ^a   Jiang, Zhaoshi ^a   Liu, Jinfeng ^a   Haverty, Peter M ^a   Guan, Yinghui ^a   Stinson, Jeremy ^a   Yue, Peng ^a   Zhang, Yan ^a   Pant, Krishna P ^b   Bhatt, Deepali ^a   Ha, Connie ^a   Johnson, Stephanie ^a   Kennemer, Michael I ^b   Mohan, Sankar ^a   Nazarenko, Igor ^b   Watanabe, Colin ^a   Sparks, Andrew B ^b   Shames, David S ^a   Gentleman, Robert ^a   De Sauvage, Frederic J ^a   Stern, Howard ^a   Pandita, Ajay ^a   Ballinger, Dennis G ^b   Drmanac, Radoje ^b   Modrusan, Zora ^a   Seshagiri, Somasekar ^a   Zhang, Zemin ^a   more..

^a GENENTECH INC   (United States)

^b Complete Genomics Inc ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; GENE EXPRESSION; GENOMICS; MORTALITY; MUTATION; NUCLEAR MAGNETIC RESONANCE; NUCLEIC ACID; SMOKING; TUMOR;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER MORTALITY; CONTROLLED STUDY; GENE MUTATION; GENE SEQUENCE; HUMAN; HUMAN TISSUE; LEUKEMIA; LUNG CANCER; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROMOTER REGION; PROTO ONCOGENE; SMOKING; SOMATIC MUTATION;

CARCINOMA, NON-SMALL-CELL LUNG; DNA MUTATIONAL ANALYSIS; GENOME, HUMAN; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; POINT MUTATION; SELECTION, GENETIC;

EID: 77953006634     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature09004     Document Type: Article

References (29)

1. Parkin D. M., Bray F., Ferlay J., Pisani P. Global cancer statistics 2002. CA Cancer J. Clin. 55, 74-108 (2005).
2. Herbst, R. S., Heymach, J. V. & Lippman, S. M. Lung cancer. N. Engl. J. Med. 359, 1367-1380 (2008).
3. Campbell, P. J. et al. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing. Nature Genet. 40, 722-729 (2008).
4. Davies, H. et al. Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res. 65, 7591-7595 (2005).
5. Ding, L. et al. Somatic mutations affect key pathways in lung adenocarcinoma. Nature 455, 1069-1075 (2008).
6. Greenman, C. et al. Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158 (2007).
7. Stratton, M. R., Campbell, P. J. & Futreal, P. A. The cancer genome. Nature 458, 719-724 (2009).
8. Weir, B. A. et al. Characterizing the cancer genome in lung adenocarcinoma. Nature 450, 893-898 (2007).
9. Mardis, E. R. et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N. Engl. J. Med. 361, 1058-1066 (2009).
10. Ley, T. J. et al. DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome. Nature 456, 66-72 (2008).
11. Shah, S. P. et al. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution. Nature 461, 809-813 (2009).
12. Pleasance, E. D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191-196 (2009).
13. Pleasance, E. D. et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 463, 184-190 (2010).
14. Hecht, S. S. Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst. 91, 1194-1210 (1999).
15. Chu, P. G. & Weiss, L. M. Expression of cytokeratin 5/6 in epithelial neoplasms: an immunohistochemical study of 509 cases. Mod. Pathol. 15, 6-10 (2002).
16. Tan, D. et al. Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study. Hum. Pathol. 34, 597-604 (2003).
17. Wistuba, I. I. & Gazdar, A. F. Lung cancer preneoplasia. Annu. Rev. Pathol. 1, 331-348 (2006).
18. Drmanac, R. et al. Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science 327, 78-81 (2010).
19. Forbes, S. A. et al. The catalogue of somatic mutations in cancer (COSMIC). Curr. Protoc. Hum. Genet. doi:10.1002/0471142905.hg1011s57 (2008).
20. Stenson, P. D. et al. The human gene mutation database: 2008 update. Genome Med. 1, 13 (2009).
21. Hicks, J. et al. Novel patterns of genome rearrangement and their association with survival in breast cancer. Genome Res. 16, 1465-1479 (2006).
22. Beroukhim, R. et al. Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. Proc. Natl Acad. Sci. USA 104, 20007-20012 (2007).
23. Bignell, G. R. et al. Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution. Genome Res. 17, 1296-1303 (2007).
24. Soda, M. et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature 448, 561-566 (2007).
25. Lin, E. et al. Exon array profiling detects EML4-ALK fusion in breast, colorectal, and non-small cell lung cancers. Mol. Cancer Res. 7, 1466-1476 (2009).
26. Rowley, J. D. A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243, 290-293 (1973).
27. Tomlins, S. A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 644-648 (2005).
28. Krzywinski, M. et al. Circos: an information aesthetic for comparative genomics. Genome Res. 19, 1639-1645 (2009).
29. Dhillon, A. S., Hagan, S., Rath, O. & Kolch, W. MAP kinase signalling pathways in cancer. Oncogene 26, 3279-3290 (2007).